Visceral leishmaniasis mimicking systemic lupus erythematosus

Visceral leishmaniasis mimicking systemic lupus erythematosus

Abstract Visceral leishmaniasis (VL), or kala-azar, a serious disease resulting from a systemic infection caused by a protozoan of the genus Leishmania, is potentially fatal to humans. According to data from Sistema de Informação de Agravos de Notificação (Brazil's Information System for Notifi...

Full description

Bibliographic Details
Main Authors:	Greyce Christine Lisboa Bueno, Amanda Terra de Sá Koerich, Luciana Bonnassis Burg, Sara Letícia Kretzer, Joanita Ângela Gonzaga Del Moral, Ivânio Alves Pereira
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2019-02-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Leishmaniasis Kala-azar Systemic lupus erythematosus
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100703&lng=en&tlng=en

Similar Items

Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: A possible challenge to elimination program in India
by: VNR Das, et al.
Published: (2013-01-01)

Visceral Leishmaniasis in Iran: Review of the Epidemiological and Clinical Features
by: Mehdi Mohebali
Published: (2013-09-01)

Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features
by: Mehdi Mohebali
Published: (2013-09-01)

Visceral Leishmaniasis (Kala-Azar) Outbreak in Somali Refugees and Kenyan Shepherds, Kenya
by: Günter Boussery, et al.
Published: (2001-06-01)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013-01-01)

Epidemiology of human visceral leishmaniasis in the urban centers of the lower-middle São Francisco Valley, Brazilian semiarid region
by: Lucyo Flávio Bezerra Diniz, et al.

Immune responses in post kala-azar dermal leishmaniasis
by: Mitali Chatterjee, et al.
Published: (2020-01-01)

Treatment cost on Visceral Leishmaniasis: Case study in endemic districts of Nepal
by: Dharanidhar Baral
Published: (2016-08-01)

Visceral leishmaniasis and glomerulonephritis: A case report
by: Marwan Jabr Alwazzeh, et al.
Published: (2019-01-01)

Seroepidemiological Study of Visceral Leishmaniasis (Kala-azar) in Ardabil Province, Iran, 1986 – 2009
by: S Molaie, et al.
Published: (2010-10-01)

Visceral Leishmaniasis in Southeastern Iran: A Narrative Review
by: Iraj SHARIFI, et al.
Published: (2017-02-01)

Visceral Leishmaniasis during Italian Renaissance, 1522–1562
by: Andreas G. Nerlich, et al.
Published: (2012-01-01)

Congenital Visceral Leishmaniasis
by: Catharina C. Boehme, et al.
Published: (2006-02-01)

Mathematical modelling of the use of insecticide-treated nets for elimination of visceral leishmaniasis in Bihar, India
by: Anna K. Fortunato, et al.
Published: (2021-06-01)

Human Visceral Leishmaniasis in Kermanshah Province, Western Iran, During 2011-2012
by: H Bashiri, et al.
Published: (2012-12-01)

Human Visceral Leishmaniasis in Kermanshah Province, Western Iran, During 2011-2012
by: Y. Hamzavi, et al.
Published: (2015-10-01)

STUDY OF VISCERAL LEISHMANIASIS (KALAAZAR) CASES IN TEHRAN, NECESSITY OF EARLY DIAGNOSIS AND PREVENTION
by: M. jalali, et al.
Published: (1999-12-01)

Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs
by: Huda M, et al.
Published: (2012-11-01)

QBC® for the diagnosis of human and canine american visceral leishmaniasis: preliminary data
by: Liarte Daniel B., et al.
Published: (2001-01-01)

Immunobiology of visceral leishmaniasis
by: Susanne eNylén, et al.
Published: (2012-08-01)

Study on Changes in Epidemiological Patterns and Parameters of Visceral Leishmaniasis in Patients Referred to Health Care Centers of Meshkin Shahr during 2001-2012: (A Retrospective Study)
by: Eslam Moradi Asl, et al.
Published: (2014-04-01)

Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil
by: Elizabeth F. Daher, et al.

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Achiléa Bittencourt, et al.

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2003-01-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Achiléa Bittencourt, et al.

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Bittencourt Achiléa, et al.
Published: (2002-01-01)

Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010
by: Iúri Paz Lima, et al.
Published: (2013-09-01)

Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010
by: Iúri Paz Lima, et al.
Published: (2013-04-01)

Post kala-azar dermal leishmaniasis: Clinical features and differential diagnosis
by: Piyush Kumar, et al.
Published: (2021-01-01)

Comparison of conventional methods for diagnosis of visceral leishmaniasis in children of the Center-West Region of Brazil
by: Yvone M. Brustoloni, et al.

Expansion of visceral leishmaniasis to northwest sub-Himalayan region of India: A case series
by: Sujeet Raina, et al.
Published: (2016-01-01)

EXPANSION OF VISCERAL LEISHMANIASIS IN THE STATE OF RIO DE JANEIRO, BRAZIL: REPORT OF THE FIRST AUTOCHTHONOUS CASE IN THE MUNICIPALITY OF VOLTA REDONDA AND THE DIFFICULTY OF DIAGNOSIS
by: Luiz Henrique Conde Sangenis, et al.
Published: (2014-06-01)

Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis
by: Anke E. Kip, et al.
Published: (2018-06-01)

Visceral leishmaniasis: An immunological viewpoint on asymptomatic infections and post kala azar dermal leishmaniasis
by: Neeraj Tiwari, et al.
Published: (2018-01-01)

An overview of Leishmaniasis with a focus on the island of Cyprus
by: Namık Refik Kerkuklu, et al.
Published: (2020-01-01)

Acute erythroid toxicity in visceral leishmaniasis: A rare complication of antimonial therapy
by: Sharma Sunita, et al.
Published: (2008-10-01)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
by: Wim Adriaensen, et al.
Published: (2018-01-01)

Plasma levels of tumor necrosis factor-alpha in patients with visceral leishmaniasis (Kala-Azar). Association with activity of the disease and clinical remisson following antimonial therapy Níveis plasmáticos do fator de necrose tumoral-alfa (TNF-alfa) em pacientes com leishmaniose visceral (Calazar). Associação com atividade da doença e remissão clínica com terapia antimonial
by: Reinaldo Salomão, et al.
Published: (1996-04-01)

Challenges in modeling complexity of neglected tropical diseases: a review of dynamics of visceral leishmaniasis in resource limited settings
by: Swati DebRoy, et al.
Published: (2017-09-01)

Seroprevalence and risk factors for canine visceral leishmaniasis in the endemic area of Dias D'Ávila, State of Bahia, Brazil Soroprevalência e fatores de risco para leishmaniose visceral canina na área endêmica de Dias D'Ávila, Estado da Bahia, Brasil
by: Laura Cristina Pinho de Oliveira, et al.
Published: (2010-08-01)

Cannot write session to /tmp/vufind_sessions/sess_afsdgueui74bofk2jje9sdgrl8